Benzyl-substituted benzimidazoles
    11.
    发明授权
    Benzyl-substituted benzimidazoles 失效
    苄基取代的苯并咪唑

    公开(公告)号:US06465505B1

    公开(公告)日:2002-10-15

    申请号:US08875132

    申请日:1997-07-17

    IPC分类号: A61K314184

    CPC分类号: A61K31/4184 C07D235/08

    摘要: The present invention relates to benzimidazole derivatives of the formula (I), in which the phenyl moiety is substituted with lower alkyl in 2- and 6-position, which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastrointestinal inflammatory diseases.

    摘要翻译: 本发明涉及式(I)的苯并咪唑衍生物,其中苯基部分被2-和6-位的低级烷基取代,其抑制外源或内源性刺激的胃酸分泌,因此可用于预防和 治疗胃肠道炎症性疾病。

    Salts of omeprazole and esomeprazole II
    13.
    发明申请
    Salts of omeprazole and esomeprazole II 失效
    奥美拉唑和埃索美拉唑盐

    公开(公告)号:US20070021467A1

    公开(公告)日:2007-01-25

    申请号:US10569820

    申请日:2004-09-01

    IPC分类号: A61K31/4439 C07D403/02

    CPC分类号: C04B35/632 C07D401/12

    摘要: The present invention relates to new salts of the single enantiomers of omeprazole, i.e. salts of (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole ((S)-omeprazole) and (R)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole ((R)-omeprazole) respectively. More specifically, the present invention relates to 1-cyclohexylethyl ammonium salts of the compounds, formed by a reaction of (S)-omeprazole and (R)-omeprazole respectively and 1-cyclohexylethyl amine. The present invention also relates to a process for preparing the compounds of the invention, a pharmaceutical preparation and a method for treatment of gastric related disorders by administering the compounds of the invention.

    摘要翻译: 本发明涉及奥美拉唑的单一对映异构体的新盐,即(S)-5-甲氧基-2 - [[(4-甲氧基-3,5-二甲基-2-吡啶基) - 甲基]亚磺酰基] - ((S) - 奥美拉唑)和(R)-5-甲氧基-2 - [[(4-甲氧基-3,5-二甲基-2-吡啶基) - 甲基]亚磺酰基] -1H-苯并咪唑((R ) - 奥美拉唑)。 更具体地,本发明涉及通过(S) - 奥美拉唑和(R) - 奥美拉唑与1-环己基乙胺的反应形成的化合物的1-环己基乙基铵盐。 本发明还涉及通过施用本发明的化合物制备本发明化合物的方法,药物制剂和治疗胃相关疾病的方法。

    Imidazo pyridine derivatives which inhibit gastric acid secretion
    15.
    发明授权
    Imidazo pyridine derivatives which inhibit gastric acid secretion 失效
    抑制胃酸分泌的咪唑吡啶衍生物

    公开(公告)号:US06313136B1

    公开(公告)日:2001-11-06

    申请号:US09319890

    申请日:1999-06-14

    IPC分类号: A61K31435

    CPC分类号: C07D471/04

    摘要: The present invention relates to imidazo pyridine derivatives of the formula (I), in which the phenyl moiety is substituted, and in which the imidazo pyridine moiety is substituted with a carboxamide group in 6-position, which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastrointestinal inflammatory diseases.

    摘要翻译: 本发明涉及式(I)的咪唑并吡啶衍生物,其中苯基部分被取代,其中咪唑并吡啶部分被6位的羧酰胺基团取代,其抑制外源或内源性刺激的胃酸分泌 因此可用于预防和治疗胃肠道炎性疾病。